Navigation Links
Novel handheld device detects anthrax with outstanding accuracy and reliability
Date:6/25/2009

Baltimore, MD, and Christchurch, NZ June 25, 2009 Veritide Ltd., a developer of innovative biological identification and detection solutions, today reported that new independent data to be presented at the Biodetection Technologies 2009 conference confirm the exceptional accuracy of its Ceeker (pronounced "seeker") portable bacterial detection device in discriminating between anthrax spores and similar-looking hoax substances. The data show that in over two weeks of testing at the Midwest Research Institute in Florida, the company's Ceeker scanner accurately identified 100% of the anthrax samples used and was correct in 95% of tests involving hoax substances. These test results are consistent with similar results produced last year by a New Zealand forensic testing agency, Environmental Science and Research (ESR).

"We knew that our innovative Ceeker is capable of producing outstanding results in distinguishing between anthrax and look-alike hoax substances, and now we have definitive data confirming its performance," said Andrew Rudge, Ph.D., Chief Executive Officer of Veritide. "Even better, these extraordinary results were generated by a small portable handheld system that requires no special skills or training to operate and that can produce a result within minutes, enabling first responders to rapidly determine whether the situation is a nuisance or a major threat to public health."

The Ceeker employs optical detection technology developed at New Zealand's University of Canterbury. It uses ultraviolet light and special algorithms to detect bacterial spores and provides test results within minutes, without the need for wet chemistry or analytic processes that can be difficult to handle in the field. The Ceeker is capable of producing test results from very small amounts of sample and does not consume or destroy the sample being tested, allowing it to be re-analyzed later for forensic applications.

In contrast, existing detection approaches require longer and more complex processing to distinguish anthrax from other substances (between 30 minutes and three days), their accuracy is inferior to the Ceeker and the sample is typically destroyed during testing.

The new data will be presented on June 26, 2009 at Biodetection Technologies 2009 by Professor Lou Reinisch, an inventor of the Ceeker technology and Professor of Physics and Department Head at Jacksonville State University in Alabama. Prof. Reinisch noted, "It is gratifying to present these outstanding results from a system that has so much potential to reduce the large costs and losses in productivity and peace of mind caused by our current inability to easily distinguish between anthrax spores and harmless white powder. These new data definitively confirm the validity of the detection concepts underlying the Ceeker and should help fuel its wider use among such first responders as fire and police departments, HazMat teams, postal services, port and airport security, and defense and military authorities."

John Delaney is Captain, Arlington County, Virginia Fire Department and Manager, National Medical Response Team-National Capital Region, home to the Pentagon and many other major U.S. government and corporate facilities. Capt. Delaney commented, "With responsibility for helping to ensure the safety of the hundreds of thousands of people who live and work in the Capital Region, my department welcomes the availability of technologically advanced solutions that enhance our ability to carry out our mission. The Veritide Ceeker is an excellent exampleit is extremely versatile, easy-to-use and fastresults are ready in minutes. Most importantly, the new test data being presented this week confirm that the Ceeker is very reliable, enabling front-line decision makers to rapidly and confidently validate initial threat assessments that can ultimately have a far-reaching impact on public safety and well-being. The National Capital Region generally receives on average one alert a day or more regarding the potential presence of anthrax, so this device can only enhance our first responder capabilities and accuracy."

The Ceeker has also been previously validated by forensic laboratory ESR, which conducted multiple rounds of testing using anthrax simulants and hoax substances. The successful U.S. test results have triggered significant sales from U.S. customers who had pre-ordered the Ceeker but were waiting for positive direct anthrax testing results before proceeding.

Dr. Rudge added, "Achieving these results represents a significant milestone and positions Veritide as the first company to offer proven technology capable of accurately and reliably detecting lethal anthrax spores, and to do so without destroying the sample. These new testing results are expected to unlock large potential markets for Veritide in North America and around the globe. We currently are in the process of identifying potential partners and additional investors to ensure this important technology is available worldwide."


'/>"/>

Contact: Barbara Lindheim
212-918-4650
BioCom Partners
Source:Eurekalert

Related biology news :

1. International collaboration by scientists culminates in novel ion channels database
2. UC Davis grant zeroes in on novel asthma diagnosis and treatment
3. Novel vaccine approach offers hope in fight against HIV
4. ExcellGene and Khner achieved milestone in development of novel 250 Liter mammalian cell culture bioreactors
5. Study finds novel genetic risk factors for kidney disease
6. Novel antibody prevents infection by hepatitis C virus
7. IVCC and Syngenta start project for novel insecticidal active ingredient for malaria control
8. Novel lung cancer vaccine shows promise in fighting early-stage lung cancer
9. MIT: Novel needle could cut medical complications
10. Ocera Therapeutics licenses novel treatment for acute hepatic encephalopathy from UCLB
11. Novel electric signals in plants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/25/2016)... --  Unisys Corporation (NYSE: UIS ) today announced the ... Airport, New York City , to help ... enter the United States using passports that ... testing of the system at Dulles last year. The system ... January 2016. --> pilot testing of the system ...
(Date:1/20/2016)... -- A market that just keeps on growing. Molecular ... in genomics knowledge. Learn all about it in this ... dynamic trends are pushing market growth and company valuations. ... - pathogen evolution - next generation sequencing - emergence ... of the role of genetic material in Disease and ...
(Date:1/13/2016)... , January 13, 2016 ... has published a new market report titled - Biometric Sensors ... and Forecast, 2015 - 2023. According to the report, the global ... and is anticipated to reach US$1,625.8 mn by 2023, ... 2023. In terms of volume, the biometric sensors market ...
Breaking Biology News(10 mins):
(Date:2/10/2016)... - BioAmber Inc. (NYSE: BIOA ), a leader ... & Co. Ltd., its partner in the ... an additional CDN$25 million in the joint venture for ... to 40%.  Mitsui will also play a stronger role ... Sarnia , providing dedicated resources alongside BioAmber,s ...
(Date:2/10/2016)... NX Prenatal Inc., a US based ... for early warning of adverse pregnancy outcomes, announced ... by Dr. Thomas McElrath of Brigham ... Medicine,s (SMFM) annual meeting held in ... The presentation reported initial positive top-line results regarding ...
(Date:2/10/2016)... RICHLAND, Wash., Feb. 10, 2016  IsoRay, Inc. (NYSE ... seed brachytherapy and medical radioisotope applications for the treatment ... cancers, today announced its financial results for the second ... December 31, 2015. --> ... second quarter of fiscal 2016, which ended December 31, ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... three states, announced today the promotion of two long-standing principal investigators (PI) to ... Family Medicine, Clinical Research and Development. , Dr. Laurence Chu, a Benchmark Research ...
Breaking Biology Technology: